![Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose - ScienceDirect Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1818087616302094-ajps418-fig-0007.jpg)
Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose - ScienceDirect
![Extended-Release vs Sustained-Release | How Do Extended-Release & Sustained-Release Tablets Work - UPM Pharmaceuticals Extended-Release vs Sustained-Release | How Do Extended-Release & Sustained-Release Tablets Work - UPM Pharmaceuticals](https://www.upm-inc.com/hubfs/Drug_Delivery_Dynamics/extended-release-tablets.jpg)
Extended-Release vs Sustained-Release | How Do Extended-Release & Sustained-Release Tablets Work - UPM Pharmaceuticals
![Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy](https://c8.alamy.com/comp/WPHK7W/octasa-400-mg-modified-release-tablets-active-substance-mesalazine-used-to-treat-mild-to-moderate-attacks-of-ulcerative-colitis-WPHK7W.jpg)
Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy
![Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde-2016-0026/asset/images/medium/figure1.gif)
Advances in mechanistic understanding of release rate control mechanisms of extended-release hydrophilic matrix tablets | Therapeutic Delivery
![Difference Between Sustained-release, Prolonged-release, and Extended-release Tablets | imdip - imdip - Be a smart pharmacist. Difference Between Sustained-release, Prolonged-release, and Extended-release Tablets | imdip - imdip - Be a smart pharmacist.](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiz86W3q7YaCJjHR29WtzhNYJdgirfw6HFlyGSkFo03WmLpOiezj_qv46e2Q0WGrSbUNjnTxcKWBziyLfJ5qmSmWvbH7BAlE0HpPYXGalUNlkjA7J7GjYxbjica-gjiMzwsNZw2-q7KiI7l4gXMt4kj3rHX_Y6_QgV0J5WOEw64rj54mZI2SEiEszC-Cw/s16000/Difference%20between%20Sustained-release,%20Prolonged-release,%20and%20Extended-release%20Tablets.jpg)
Difference Between Sustained-release, Prolonged-release, and Extended-release Tablets | imdip - imdip - Be a smart pharmacist.
![Various Modified Tablets | Sustained release tablet | Multilayered tablets | Pharmaceutics DPharm1st - YouTube Various Modified Tablets | Sustained release tablet | Multilayered tablets | Pharmaceutics DPharm1st - YouTube](https://i.ytimg.com/vi/vFgPCsNcWuI/hqdefault.jpg)